Fc-MST-HN was not effective in the preventive ITP model at 50 mg/kg, likely because determining platelet counts up to 24h is not long enough to allow the anti-FcRn drug to substantially affect IgG elimination. This evidence concerns the gene FCGRT and autoimmune thrombocytopenic purpura.